190 related articles for article (PubMed ID: 19444514)
1. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma.
Boller D; Spieler P; Schoenegg R; Neuweiler J; Kradolfer D; Studer R; Grossenbacher R; Zuercher U; Meyenberger C; Borovicka J
Surg Endosc; 2009 Dec; 23(12):2748-54. PubMed ID: 19444514
[TBL] [Abstract][Full Text] [Related]
2. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
[TBL] [Abstract][Full Text] [Related]
3. Evaluating synchronous esophageal cancer in head and neck cancer patients using Lugol dye chromoendoscopy.
Laohawiriyakamol S; Sunpaweravong S; Leelamanit V; Pruegsanusak K; Sinkijcharoenchai W
J Med Assoc Thai; 2014 Nov; 97(11):1164-70. PubMed ID: 25675681
[TBL] [Abstract][Full Text] [Related]
4. Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus.
Fagundes RB; de Barros SG; Pütten AC; Mello ES; Wagner M; Bassi LA; Bombassaro MA; Gobbi D; Souto EB
Endoscopy; 1999 May; 31(4):281-5. PubMed ID: 10376452
[TBL] [Abstract][Full Text] [Related]
5. Fujinon intelligent color enhancement for the diagnosis of early esophageal squamous cell carcinoma and precancerous lesion.
Li YX; Shen L; Yu HG; Luo HS; Yu JP
Turk J Gastroenterol; 2014 Aug; 25(4):365-9. PubMed ID: 25254516
[TBL] [Abstract][Full Text] [Related]
6. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of lugol chromoendoscopy in the oesophagus in patients with head and neck cancer.
Carvalho R; Areia M; Brito D; Saraiva S; Alves S; Cadime AT
Rev Esp Enferm Dig; 2013 Feb; 105(2):79-83. PubMed ID: 23659506
[TBL] [Abstract][Full Text] [Related]
9. Lugol staining and histological evaluation of esophageal mucosa in achalasia.
Yamamuro EM; Cecconello I; Iriya K; El Ibrahim R; Rodrigues JG; Pinotti HW
Hepatogastroenterology; 2006; 53(70):506-10. PubMed ID: 16995450
[TBL] [Abstract][Full Text] [Related]
10. Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China.
Li J; Xu R; Liu M; Cai H; Cao C; Liu F; Li F; Guo C; Pan Y; He Z; Ke Y
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1585-1592. PubMed ID: 29174712
[TBL] [Abstract][Full Text] [Related]
11. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
Morita FH; Bernardo WM; Ide E; Rocha RS; Aquino JC; Minata MK; Yamazaki K; Marques SB; Sakai P; de Moura EG
BMC Cancer; 2017 Jan; 17(1):54. PubMed ID: 28086818
[TBL] [Abstract][Full Text] [Related]
12. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
Gruner M; Denis A; Masliah C; Amil M; Metivier-Cesbron E; Luet D; Kaasis M; Coron E; Le Rhun M; Lecleire S; Antonietti M; Legoux JL; Lefrou L; Renkes P; Tarreirias AL; Balian P; Rey P; Prost B; Cellier C; Rahmi G; Samaha E; Fratte S; Guerrier B; Landel V; Touzet S; Ponchon T; Pioche M
Endoscopy; 2021 Jul; 53(7):674-682. PubMed ID: 32698233
[TBL] [Abstract][Full Text] [Related]
13. Pre-procedure oral administration of pronase improves efficacy of lugol chromoendoscopy in esophageal squamous cell carcinoma screening: a prospective, double-blinded, randomized, controlled trial.
Zhao X; Guo M; Zhu S; Zhang L; Dong T; Luo H; Yu W; Zhu J; Fan X; Han Y; Liu Z
Surg Endosc; 2023 Jun; 37(6):4421-4430. PubMed ID: 36781469
[TBL] [Abstract][Full Text] [Related]
14. Narrow-band imaging without magnification for detecting early esophageal squamous cell carcinoma.
Ide E; Maluf-Filho F; Chaves DM; Matuguma SE; Sakai P
World J Gastroenterol; 2011 Oct; 17(39):4408-13. PubMed ID: 22110267
[TBL] [Abstract][Full Text] [Related]
15. Delineating the extent of esophageal squamous cell carcinoma.
Kono M; Kanesaka T; Ishihara R; Kitamura M; Shoji A; Inoue T; Matsueda K; Miyake M; Waki K; Shimamoto Y; Fukuda H; Iwagami H; Matsuura N; Nakahira H; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Nakatsuka SI; Fujiwara Y
Esophagus; 2021 Oct; 18(4):790-796. PubMed ID: 34052934
[TBL] [Abstract][Full Text] [Related]
16. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus.
Fritcher EG; Brankley SM; Kipp BR; Voss JS; Campion MB; Morrison LE; Legator MS; Lutzke LS; Wang KK; Sebo TJ; Halling KC
Hum Pathol; 2008 Aug; 39(8):1128-35. PubMed ID: 18602665
[TBL] [Abstract][Full Text] [Related]
17. Lugol dye endoscopy for analysis of esophageal mucosa in achalasia.
Yamamuro EM; Cecconello I; Iriya K; Tomishigue T; Oliveira MA; Pinotti HW
Hepatogastroenterology; 1999; 46(27):1687-91. PubMed ID: 10430322
[TBL] [Abstract][Full Text] [Related]
18. Image cytometric DNA analysis of mucosal biopsies in patients with primary achalasia.
Gockel I; Kammerer P; Brieger J; Heinrich UR; Mann WJ; Bittinger F; Eckardt VF; Junginger T
World J Gastroenterol; 2006 May; 12(19):3020-5. PubMed ID: 16718781
[TBL] [Abstract][Full Text] [Related]
19. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis.
Bugter O; van de Ven SEM; Hardillo JA; Bruno MJ; Koch AD; Baatenburg de Jong RJ
Head Neck; 2019 Apr; 41(4):1122-1130. PubMed ID: 30593712
[TBL] [Abstract][Full Text] [Related]
20. p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?
Fagundes RB; Melo CR; Pütten AC; Moreira LF; de Barros SG
Cancer Detect Prev; 2005; 29(3):227-32. PubMed ID: 15936591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
